Eosinophilic gastritis

1 trials 1 recruiting MedDRA PT
1 Registered trials
1 Recruiting
1 Unique sponsors
1 Unique IMPs
1 Commercial trials
Drug classes (ATC)
D Dermatology (ATC D) 1
Mechanism of action (INN-stem analysis)
Monoclonal antibody 1 substance
Phase II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase II

1 trial
  • Regeneron Pharmaceuticals Inc. Commercial
    DUPILUMAB
    2022-500795-62-00 3 countries 2024 n=19
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Regeneron Pharmaceuticals Inc. Commercial 1 Phase II 1
New trials by year
2024
1
← All indication landscapes